Literature DB >> 18514327

Elevated nailfold plexus visibility aggregates in families and is associated with a specific negative symptom pattern in schizophrenia.

John P Vuchetich1, Jennifer L Liska, Daphne P Dionisio, John J Stanwyck, Kathryn A McGuire, Scott R Sponheim.   

Abstract

Twenty-four individuals with schizophrenia and 28 of their first-degree biological relatives were studied using clinical scales, functional ratings, and neuropsychological tests. An assessment of Nailfold Plexus Visibility (NPV) was also performed on these individuals. In keeping with the literature, we found an increased prevalence of high NPV in our schizophrenia subjects relative to controls and community norms, and also found that high NPV patients had significantly more negative symptoms and poorer social functioning. Measures of negative symptoms indicative of the deficit syndrome did a better job of distinguishing high from low NPV subjects than did more broadly defined negative symptom indices. As predicted, the prevalence of high NPV in first-degree relatives of high NPV schizophrenia subjects was increased compared with relatives of low NPV schizophrenia subjects. These two relative groups did not differ on overall level of schizotypy symptoms or on negative symptom schizotypy indices. However, relatives of low NPV patients scored significantly higher on scales of positive symptom schizotypy. Overall, these results support the hypothesis that high NPV is a marker of risk for a distinct subtype of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514327      PMCID: PMC6379205          DOI: 10.1016/j.psychres.2007.04.024

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  34 in total

1.  Replication of linkage studies of complex traits: an examination of variation in location estimates.

Authors:  S B Roberts; C J MacLean; M C Neale; L J Eaves; K S Kendler
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  Elevated levels of cognitive-perceptual deficits in individuals with a family history of schizophrenia spectrum disorders.

Authors:  P S Yaralian; A Raine; T Lencz; J M Hooley; S E Bihrle; S Mills; J Ventura
Journal:  Schizophr Res       Date:  2000-11-30       Impact factor: 4.939

3.  CAPILLARY MORPHOLOGY OF THE NAILFOLD IN THE MENTALLY ILL.

Authors:  A S NORRIS; J R CHOWNING
Journal:  J Neuropsychiatr       Date:  1964-04

4.  Capillary structure: its relation to psychiatric diagnosis and morphology.

Authors:  N WERTHEIMER; M WERTHEIMER
Journal:  J Nerv Ment Dis       Date:  1955-07       Impact factor: 2.254

5.  Relationship between nailfold plexus visibility and clinical, neuropsychological, and brain structural measures in schizophrenia.

Authors:  C E Curtis; W G Iacono; M Beiser
Journal:  Biol Psychiatry       Date:  1999-07-01       Impact factor: 13.382

6.  Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale.

Authors:  J Ventura; K H Nuechterlein; K L Subotnik; D Gutkind; E A Gilbert
Journal:  Psychiatry Res       Date:  2000-12-27       Impact factor: 3.222

7.  Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging.

Authors:  K O Lim; M Hedehus; M Moseley; A de Crespigny; E V Sullivan; A Pfefferbaum
Journal:  Arch Gen Psychiatry       Date:  1999-04

Review 8.  The endophenotype concept in psychiatry: etymology and strategic intentions.

Authors:  Irving I Gottesman; Todd D Gould
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

Review 9.  A separate disease within the syndrome of schizophrenia.

Authors:  B Kirkpatrick; R W Buchanan; D E Ross; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  2001-02

10.  Sensitivity and specificity of select biological indices in characterizing psychotic patients and their relatives.

Authors:  Scott R Sponheim; William G Iacono; Paul D Thuras; Sean M Nugent; Morton Beiser
Journal:  Schizophr Res       Date:  2003-09-01       Impact factor: 4.939

View more
  1 in total

1.  Genome-wide gene pathway analysis of psychotic illness symptom dimensions based on a new schizophrenia-specific model of the OPCRIT.

Authors:  Anna R Docherty; T Bernard Bigdeli; Alexis C Edwards; Silviu Bacanu; Donghyung Lee; Michael C Neale; Brandon K Wormley; Dermot Walsh; F Anthony O'Neill; Brien P Riley; Kenneth S Kendler; Ayman H Fanous
Journal:  Schizophr Res       Date:  2015-03-13       Impact factor: 4.939

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.